The global allergy immunotherapy market is anticipated to grow at a CAGR 8.2% during the forecast period. The factor such as increasing awareness of allergies in the patients is anticipated to propel the growth of the allergy immunotherapy industry. According to the World Allergy Organization, an increase in the pervasiveness of allergies has been witnessed and around 30% of the world population has allergic rhinitis. As per the Centers for Disease Control and Prevention (CDC), more than 8% of the adults in the US suffer from sinusitis and hay fever. The awareness created by these organizations, governments of different countries has sanctioned budget for the R&D of allergy immunotherapy as an effective cure. Thus, this factor has a positive impact on the growth of the allergy immunotherapy market during the forecast period.

Get Sample Copy of Allergy Immunotherapy Market at: https://www.omrglobal.com/request-sample/allergy-immunotherapy-market

The key players of allergy immunotherapy market includeBiomay AG, Aimmune Therapeutics, Inc., HAL Allergy Group, Allergopharma, Merck KGaA, Stallergenes Greer, Jubilant Life Sciences, Ltd., ALK-Abello A/S, Leti Pharma, and DBV Technologies.

The factor such as the growing prevalence of gastrointestinal diseases, rising investments, and funding in the field of life science research that boost the growth of the allergy immunotherapy market during the forecast period. Allergy immunotherapy is also known as hypo-sensitization. It is a type of medical treatment that allows for tackling various types of allergies. There has been significant growth in the various types of allergies across the globe. Pharmacotherapy is not enough to tackle and control the occurrence of these allergic disorders. Therefore, it is a major driving factor for the development of the allergy immunotherapy market. The use of these treatments enables in building up the tolerance level against the allergic substances and enables in altering the course of the disorders.

A full report of Global Allergy Immunotherapy Market is available at: https://www.omrglobal.com/industry-reports/allergy-immunotherapy-market

The global allergy immunotherapy market is segmented on the basis of treatment, type and distribution channel. Based on type, the market segmented into allergic rhinitis, allergicasthma, food allergy, drug allergy, and others. The asthma segment is expected to hold a significant market share due to the growing prevalence of asthma across the globe. Based on treatment, the market is bifurcated into subcutaneous immunotherapy and sublingual immunotherapy. The subcutaneous immunotherapy segment is expected to hold a considerable growth rate during the forecast period due to its effectiveness to treat several allergies such as asthma. Moreover, it is treatment options that have to alter one's immune system to cure the development of other allergies. Based on the distribution channel, the market is sub-segmented into hospital pharmacy, retail pharmacy, and online pharmacy.

Market Segmentation

Global Allergy Immunotherapy Market by Type

• Allergic Rhinitis
• Allergic Asthma
• Food Allergy
• Drug Allergy
• Others

Global Allergy Immunotherapy Market by Treatment

• Subcutaneous Immunotherapy
• Sublingual Immunotherapy

Global Allergy Immunotherapy Market by Distribution Channel

• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy

For more customized data, request for report customization @ https://www.omrglobal.com/report-customization/allergy-immunotherapy-market

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
For More Information, Visit https://www.omrglobal.com/

Media Contact:

Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: [email protected]
Contact no: +1 646-755-7667, +91 7803040404